Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jul;22(3):194-202.
doi: 10.1038/s41435-021-00142-8. Epub 2021 Jun 14.

Variants in BANK1 are associated with lupus nephritis of European ancestry

Affiliations
Meta-Analysis

Variants in BANK1 are associated with lupus nephritis of European ancestry

Karin Bolin et al. Genes Immun. 2021 Jul.

Abstract

The genetic background of lupus nephritis (LN) has not been completely elucidated. We performed a case-only study of 2886 SLE patients, including 947 (33%) with LN. Renal biopsies were available from 396 patients. The discovery cohort (Sweden, n = 1091) and replication cohort 1 (US, n = 962) were genotyped on the Immunochip and replication cohort 2 (Denmark/Norway, n = 833) on a custom array. Patients with LN, proliferative nephritis, or LN with end-stage renal disease were compared with SLE without nephritis. Six loci were associated with LN (p < 1 × 10-4, NFKBIA, CACNA1S, ITGA1, BANK1, OR2Y, and ACER3) in the discovery cohort. Variants in BANK1 showed the strongest association with LN in replication cohort 1 (p = 9.5 × 10-4) and proliferative nephritis in a meta-analysis of discovery and replication cohort 1. There was a weak association between BANK1 and LN in replication cohort 2 (p = 0.052), and in the meta-analysis of all three cohorts the association was strengthened (p = 2.2 × 10-7). DNA methylation data in 180 LN patients demonstrated methylation quantitative trait loci (meQTL) effects between a CpG site and BANK1 variants. To conclude, we describe genetic variations in BANK1 associated with LN and evidence for genetic regulation of DNA methylation within the BANK1 locus. This indicates a role for BANK1 in LN pathogenesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Association between 112,815 SNPs and lupus nephritis in the discovery cohort.
Manhattan plot displaying results from the association analysis of 112,815 SNPs in 377 patients with lupus nephritis (LN) and 714 SLE without nephritis in the discovery cohort. The negative logarithm of the p-value is plotted against the chromosomal location of the tested variants. Genes with SNPs associated with LN with p < 1 × 10−4 are denoted.
Fig. 2
Fig. 2. Regional association plot of the BANK1 region.
Regional association plot of the BANK1 region displaying results from the analysis of LN (n = 377) versus SLE without nephritis (n = 714) in the discovery cohort. Top SNP rs4699261 is in strong linkage disequilibrium (r² ≥ 0.8) with a cluster of SNPs located in the first intronic region.
Fig. 3
Fig. 3. Genetic regulation of methylation in lupus nephritis at BANK1.
Box plot of the BANK1 meQTL rs6856202−cg01116491. SNP genotypes at rs6856202 are shown on the x-axis, methylation-beta values of CpG site cg01116491 are shown on the y-axis. The major allele (A) of rs6856202 is associated with increased methylation at cg01116491 (pmeQTL = 6.0 × 10−4) in whole blood from patients with LN. The major allele (A) is the risk allele for LN in the discovery cohort and displayed the highest signal of genetic association to proliferative nephritis in the meta-analysis of discovery and replication cohort 1 (pmeta = 1.3 × 10−5). Box plot center lines indicate medians, box boundaries indicate first and third quartile, and whiskers extend to data points located within 1.5 times the length of interquartile range from the median.

References

    1. Mahajan A, Amelio J, Gairy K, Kaur G, Levy RA, Roth D, et al. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus. 2020;29:1011–20. doi: 10.1177/0961203320932219. - DOI - PMC - PubMed
    1. Lanata CM, Nititham J, Taylor KE, Chung SA, Torgerson DG, Seldin MF, et al. Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients. PLoS ONE. 2018;13:e0199003. doi: 10.1371/journal.pone.0199003. - DOI - PMC - PubMed
    1. Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15:241–50. doi: 10.1097/01.ASN.0000108969.21691.5D. - DOI - PubMed
    1. Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, et al. Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2019;2020:713–23. - PubMed
    1. Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun. 2017;8:16021. doi: 10.1038/ncomms16021. - DOI - PMC - PubMed

Publication types

Substances